Two shots a year of a drug currently used to treat HIV infections were dramatically effective at preventing infections in a study among young women and adolescent girls in Africa. The twice-yearly ...

People at risk for contracting HIV from sex can reduce their risk of infection by up to 99% when they take pre-exposure prophylaxis (PrEP), an antiretroviral medication, as directed. However, most ...

New research shows first population-level evidence globally that a national HPV vaccination program can be highly effective ...

Beginning with the first wave of diagnoses among gay men in the early 1980s, the notion of HIV/AIDS as a “gay disease” — and one that primarily impacts gay men — has, unfortunately, persisted in the ...

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type of drug that reduces a person's risk of contracting HIV. But during a recent visit, the ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The long-acting ...

Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected cisgender women from contracting HIV in a large Phase 3 trial. In the study, none of ...

Every week, 4000 young cisgender women aged 15-24 years contract HIV globally, according to 2023 data. Infections in this age group accounted for 44% of the new global infections that year, ...

At Elton John's Oscars party, the Emmy winner highlights a persistent HIV crisis affecting Black women, especially in the South. Here's what the data shows.

While transgender women have disproportionately high rates of HIV, the population has been routinely left out of critical research involving infection prevention measures. A new study is finally ...

Estimating benefit from dose dense adjuvant chemotherapy for early breast cancer in the PANTHER randomized phase 3 trial. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...